Watch John McCamant Live!
MYOV and Other Q4 Biotech Catalysts
Wednesday, October 12, 2022 | 10:40 am – 11:10 am EDT
We expect a bidding war for MYOV and important catalysts from MDGL, TCRT, and PGEN in Q4.
Save a free spot while space remains.
Hi everyone,
As we head into Q4, the concerns plaguing investors are only getting worse. Whether it’s relentless inflation, historic interest rate hikes, reckless geopolitical rhetoric, or increasing odds of a deep recession, there are plenty of reasons to be fearful in today’s volatile market environment.
However, fear creates opportunity for savvy investors who are prepared. That’s why I’m excited to speak at MoneyShow’s next Accredited Investors Virtual Expo, October 11-12, along with dozens of world-class money experts.
Together, we’ll provide you with in-depth analysis and specific strategies for profiting from everything from stocks, commodities, and real estate to private placements and other alternative asset classes.
5 Reasons to Watch Live:
- Get real-time buy/sell recommendations
- Learn new strategies for reducing risk
- Hear about the Fed, inflation, and more
- Discover wealth-building tips and tactics
- Interact with the pros and fellow investors
I encourage you to save a free spot while space remains…and to bring your most important questions. Each presentation features live Q&A so you can get the answers you need to protect and grow your portfolio in the weeks ahead.
I hope to see you online,
John McCamant
Editor, Medical Technology Stock Letter